ExperimentSetReplicate

ExperimentSet4DNES694VKB2
released
View JSON

ATAC-seq on HEK293 cells - no treatment control

   February 14th, 2022 at 3:09am
Source Publication
Massively parallel genomic perturbations with multi-target CRISPR interrogates Cas9 activity and DNA repair at endogenous sites.
Zou RS, Marin-Gonzalez A, et al., Nature cell biology 2022

Experiment Set Properties  

Set Type 
Replicate
Organism 
H. sapiens
Sample Type 
immortalized cells
Sample 
HEK293 (Tier 2)
Experiment Type(s) 
ATAC-seq
Modification Type 
None
Treatment Type 
None
Assay Details 
None

5 Processed Files

Quality Metrics

Experiment
For File
Percent mitochondrial reads
Nonredundant Read Fraction (NRF)
PCR Bottleneck Coefficient (PBC)
Filtered & Deduped Reads
Report
Details
Experiment
4DNEX18DUV6G
Bio Rep 1, Tec Rep 1
ATAC-seq on HEK293 (Tier 2)
File
Read Positions (bed)
4DNFI8XQ2M8X
3.55%
0.9
0.91
60.11m
Experiment
4DNEX8F58SZJ
Bio Rep 2, Tec Rep 1
ATAC-seq on HEK293 (Tier 2)
File
Read Positions (bed)
4DNFIJG7OLQ4
5.48%
0.91
0.92
60.09m
Experiment
For File
Optimal Peaks
Rescue Ratio
Self Consistency Ratio
Fraction of Reads in Peaks
Report
Details
From Multiple Experiments
4DNES694VKB2
Multiple Experiments
File
Peaks (bigbed)
4DNFIXKN3IJB
229.95k
1.02
1.01
0.35